Active Ingredient(s): Mafenide
FDA Approved: * January 24, 1969
Pharm Company: * MYLAN BERTEK
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sulfamylon Overview

Mafenide (INN; usually as mafenide acetate, trade name Sulfamylon) is a sulfonamide-type medication used as an antibiotic. It was approved by the FDA in 1948. Contents 1 Uses 2 Mechanism of action 3 Adverse reactions 4 Drug interactions 5 Contraindications 6 Dosage 7 References 8 External links Uses Mafenide is used to treat severe burns.[1][2] It is used topically as an adjunctive therapy for second- and third-degree burns. It is bacteriostatic against...

Read more Sulfamylon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Sulfamylon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Cream: 11.2%, 85mg/gm
  • For Solution: 5%
  • Powder for Reconstitution: 5%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sulfamylon: (3 results)

Sorted by National Drug Code
  • 16571-723 Sulfamylon 85 mg/g Topical Cream by Rising Pharma Holdings, Inc.
  • 51079-623 Sulfamylon 85 mg/g Topical Cream by Mylan Institutional Inc.
  • 51079-624 Sulfamylon 50 g/1 Topical Powder, for Solution by Mylan Institutional Inc.

Other drugs which contain Mafenide or a similar ingredient: (1 result)